Compare QUALCOMM, Inc. (QCOM) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
QUALCOMM, Inc. vs UnitedHealth Group Inc — how do they compare? QUALCOMM, Inc. trades at $176.95 (market cap $182.87B), while UnitedHealth Group Inc trades at $431.6 (market cap $396.27B). The key difference: UnitedHealth Group Inc is far larger — about 2.2× QUALCOMM, Inc.'s market cap, and UnitedHealth Group Inc pays the higher dividend (2.13%). Which is the better fit depends on your goals.
| QCOM | UNH | |
|---|---|---|
Market Cap | $182.87B | $396.27B |
Sector | Technology | Health |
52-Week High | $251.10 | $436.35 |
52-Week Low | $124.07 | $237.77 |
Enterprise Value | $188.34B | $442.96B |
Dividend Yield | 2.12% | 2.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Qualcomm (QCOM) trades at $175.55, up 3.07% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 22.31% net income margin and 29.27% ROE, though margins face pressure. Analyst consensus is a $228.22 price target with 42.65% buy ratings. Recent news highlights AI and data center growth initiatives amid smartphone market challenges.
The outlook balances AI diversification potential against near-term margin and competitive risks. Investment opportunity lies in data center revenue growth and market share gains, but risks include Nvidia's PC chip entry and handset demand softness. Wall Street remains cautiously optimistic with a hold-heavy rating distribution.
UnitedHealth Group (UNH) trades at $431.31, up 2.32% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations by 29%, and maintains robust cash flow from operations of $19.70 billion in 2025. Recent news highlights strategic moves to reduce pediatric prior authorizations, aiming to improve care access and operational efficiency.
The outlook remains positive with an 82.69% analyst buy rating and a consensus price target of $476.50, implying 10.5% upside. Key risks include regulatory scrutiny, as seen in Massachusetts' $100 million Medicaid fraud lawsuit filed May 29, 2026, and margin pressure from rising medical costs. Long-term growth is supported by aging demographics and digital health investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About QUALCOMM, Inc.
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Read more on QCOM →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
